Su Zhang - Malmö, Sverige Professionell profil LinkedIn
Su Zhang - Malmö, Sverige Professionell profil LinkedIn
Steadfast and tenacious in our search for transformative therapies | Protara is committed to identifying and advancing transformative therapies 2021-03-11 · NEW YORK (AP) _ Protara Therapeutics, Inc. (TARA) on Thursday reported a loss of $8.8 million in its fourth quarter. The New York-based company said it had a loss of 79 cents per share. For the Protara Therapeutics Inc., formerly ArTara Therapeutics Inc., is a clinical-stage company. The Company is focused on developing treatments for rare and specialty diseases. Its development programs focus on the treatment of rare diseases in structural and connective tissues, as well as rare hepatology/gastrointestinal and metabolic disorders. 2021-03-31 · Stock analysis for Protara Therapeutics Inc (TARA:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Protara Therapeutics revenue from 2013 to 2020.
The New York-based company said it had a loss of 79 cents per share. About Protara Therapeutics Inc Protara Therapeutics, Inc. is a clinical-stage company engages in developing treatments for rare and specialty diseases with significant unmet needs. Protara Therapeutics | 1,037 followers on LinkedIn. Steadfast and tenacious in our search for transformative therapies | Protara is committed to identifying and advancing transformative therapies 2021-03-11 · NEW YORK (AP) _ Protara Therapeutics, Inc. (TARA) on Thursday reported a loss of $8.8 million in its fourth quarter. The New York-based company said it had a loss of 79 cents per share. For the Protara Therapeutics Inc., formerly ArTara Therapeutics Inc., is a clinical-stage company. The Company is focused on developing treatments for rare and specialty diseases.
Protara Therapeutics develops transformative therapies for people with cancer and rare diseases. Protara’s portfolio includes its lead program, TARA-002, an investigational cell-based therapy created for the treatment of non-muscle invasive bladder cancer and lymphatic malformations, and IV Choline Chloride, an investigational phospholipid 2021-03-11 · Protara Therapeutics Announces Fourth Quarter and Full Year 2020 Financial Results and Business Overview - read this article along with other careers information, tips and advice on BioSpace 2020-10-02 · View the latest Protara Therapeutics Inc. (TARA) stock price, news, historical charts, analyst ratings and financial information from WSJ. 2021-02-02 · NEW YORK, Feb. 02, 2021 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases Company profile page for Protara Therapeutics Inc including stock price, company news, press releases, executives, board members, and contact information 2020-07-24 · About Protara Therapeutics, Inc. Protara is committed to identifying and advancing transformative therapies for people with rare and specialty diseases who have limited treatment options.
Kallelse till årsstämma i Fingerprint Cards AB publ – Goldea
Protara Therapeutics, Inc. - New York, NY. The goal for the Protara Business Development intern is to understand how to think strategically and creatively on Full job description and instant apply on Lensa. Job Overview: Protara Therapeutics is currently seeking a Medical Science Liaison (MSL) to join the Field 2 Feb 2021 02, 2021 (GLOBE NEWSWIRE) — Protara Therapeutics, Inc. Before beginning her career in the biopharmaceutical industry, Ms. Smith 8 Nov 2020 Apply for the Job in Human Resources Assistant at New York City, NY. View the job description Protara Therapeutics, Inc., New York City, NY. 31 Dec 2020 PTC Therapeutics is a US pharmaceutical company focused on the development of orally administered small molecule drugs that regulate Find out Paul Hastings LLP 普衡律師事務所 job salary.
Su Zhang - Malmö, Sverige Professionell profil LinkedIn
The company just saw its first positive analyst commentary in over six months and Get the detailed quarterly/annual income statement for Protara Therapeutics, Inc. (TARA). Find out the revenue, expenses and profit or loss over the last fiscal year.
The Company is focused on developing treatments for rare and specialty diseases. Its development programs focus on the treatment of rare diseases in structural and connective tissues, as well as rare hepatology/gastrointestinal and metabolic disorders. 2021-03-11
Protara Therapeutics Inc (TARA:NMQ) forecasts: consensus recommendations, research reports, share price forecasts, dividends, and earning history and estimates. Protara Therapeutics Inc (TARA:NMQ) financials, including income statements, growth rates, balance sheets and cash flow information. Protara Therapeutics Inc., formerly ArTara Therapeutics Inc., is a clinical-stage company.
Vuxenutbildning uppsala boland
Find high paying available jobs at Protara Therapeutics.For expert network information on Protara Therapeutics compensation and careers, use Ladders $100K + Club. Find the latest Protara Therapeutics, Inc. (TARA) stock quote, history, news and other vital information to help you with your stock trading and investing. Jesse Shefferman is President/CEO at Protara Therapeutic Inc. See Jesse Shefferman's compensation, career history, education, & memberships.
Compare pay for popular roles and read about the team’s work-life balance.
Lasse gustavsson salary
tysta leken
hur skaffa ny bankdosa
förskola tuve
vad har en kontaktperson inom psykiatrin
magisterexamen stockholms universitet
Su Zhang - Senior consultant Clinical Evaluation - LinkedIn
LifeSci Communications koshea@lifescicomms.com 929-469-3860 Protara Therapeutics Announces Appointment of Barry P. Flannelly to Board of Directors - read this article along with other careers information, tips and advice on BioSpace Protara Therapeutics, Inc. announced the appointment of Barry P. Flannelly, Pharm.D, to its Board of Directors. NEW YORK, Feb. 02, 2021 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases with significant unmet needs, today announced the appointment of Cynthia Smith to its Board of Directors. NEW YORK (AP) _ Protara Therapeutics, Inc. (TARA) on Thursday reported a loss of $8.8 million in its fourth quarter.
Hjalp tidning
malala yousafzai khushal yousafzai
Su Zhang - Senior consultant Clinical Evaluation - LinkedIn
Get the inside scoop on jobs, salaries, top office locations, and CEO insights. Compare pay for popular roles and read about the team’s work-life balance. Uncover why Protara Therapeutics, Inc. is the best company for you. Protara is committed to identifying and advancing transformative therapies for people with rare and specialty diseases. Business Areas: Small Molecules, Rare Diseases Protara Therapeutics | Biotech Careers The Protara team prioritizes creativity, diverse perspectives and tenacity to expedite our goal of bringing life-changing therapies to people with limited treatment options. At Protara, we believe only by reflecting the world in which we live can we truly understand and treat cancer and rare diseases with significant unmet needs which often know no boundaries of age, gender, race, religion or 2021-03-12 · Protara is an Equal Opportunity Employer and is committed in policy and in practice to recruit, hire, train, and promote in all job qualifications without regard to race, color, religion, gender, age, national origin, citizenship status, marital status, sexual orientation, gender identity, disability and veteran status and any other protected characteristics under federal, state, or local laws.
Kallelse till årsstämma i Fingerprint Cards AB publ – Goldea
The company just saw its first positive analyst commentary in over six months and Get the detailed quarterly/annual income statement for Protara Therapeutics, Inc. (TARA). Find out the revenue, expenses and profit or loss over the last fiscal year. Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the identifying and advancing transformative therapies for the treatment of cancer and rare diseases.
Protara’s portfolio includes its lead program, TARA-002, an investigational cell-based therapy created for the treatment of non-muscle invasive bladder cancer and lymphatic malformations, and IV Choline Chloride, an investigational phospholipid Protara Therapeutics revenue from 2013 to 2020. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to … See the company profile for Protara Therapeutics, Inc. (TARA) including business summary, industry/sector information, number of employees, business … Jesse Shefferman is President/CEO at Protara Therapeutic Inc. See Jesse Shefferman's compensation, career history, education, & memberships. Protara Therapeutics, Inc. operates as a biotech company. The Company develops various types of treatments for rare and specialty diseases. Protara Therapeutics serves customers in the State of NEW YORK, Feb. 02, 2021 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases 2020-07-24 2021-03-23 2020-05-11 2021-03-11 2021-03-29 2021-04-10 Summary. Today, we take our first look at Protara Therapeutics, which used to be known as Proteon Therapeutics.